Back
From Prognosis to Practice: How Should We Use ctDNA-Guided MRD Testing in Colorectal Cancer Today?
Wednesday, January 27, 2027 at 5:30 PM to 6:00 PM · 30 min. (Europe/London)
Cancer Diagnostics Stage
Day 1 - Wednesday 27th January
Cancer
Diagnostics
Liquid Biopsy
Information
This session will explore:
What ctDNA-guided MRD testing can reliably tell us today
Key differences between Stage II and Stage III colorectal cancer
Current evidence from DYNAMIC, GALAXY, TRACC and other major studies
Speakers
Susanna Slater
Consultant Medical Oncologist
The Royal Marsden NHS Foundation Trust